Center for Pharmaceutical Policy, Management, & Service Studies
SHARE :

Study on the Availability, Price, and Affordability of Independent Blood Glucose Measuring Device in Indonesia

3
03/2021
Kategori :
Author : Administrator
Terbit : 3 Maret 2021


Study on the Availability, Price, and Affordability of Independent Blood Glucose Measuring Device in Indonesia

Study on the Availability, Price, and Affordability of Independent Blood Glucose Measuring Device in Indonesia

Collaboration with Health Action International (HAI)

Study Periode : August 2022 – February 2023

This study aims to evaluate and compare the availability, price (prive procured by government and price paid by patients/private sector) and afordability of:

  1. Self-monitoring blood glucose (SMBG) tools include a glucometer, test strips and lancets
  2. Continuous self-monitoring of blood glucose (CGS)
  3. Insulin and devices for use of insulin

The roles of CEPHAS was collectiong data from 4 provinces that include North Sumatera (medan and Labuhan Batu), NTT (Kupang and TTS), Jakarta, and West Kalimantan (Pontianan and Kapuas Hulu).

Our Projects